{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:52:20Z","timestamp":1792129940296,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01NS113871-01"],"award-info":[{"award-number":["1U01NS113871-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01NS113869-01"],"award-info":[{"award-number":["1U01NS113869-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1140297"],"award-info":[{"award-number":["APP1140297"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1156427"],"award-info":[{"award-number":["APP1156427"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1083480"],"award-info":[{"award-number":["APP1083480"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1139366"],"award-info":[{"award-number":["APP1139366"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1126378"],"award-info":[{"award-number":["APP1126378"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010721","name":"Ironwood Pharmaceuticals, Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP180101395"],"award-info":[{"award-number":["DP180101395"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["R01 115950"],"award-info":[{"award-number":["R01 115950"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DK 122280"],"award-info":[{"award-number":["DK 122280"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.tips.2021.11.002","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T18:29:36Z","timestamp":1638469776000},"page":"110-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2527-2905","authenticated-orcid":false,"given":"Stuart M.","family":"Brierley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Grundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Hannig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2021.11.002_bb0005","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tips.2021.11.002_bb0010","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(20)31548-8","article-title":"Irritable bowel syndrome","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.11.002_bb0015","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S2468-1253(19)30246-8","article-title":"Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis","volume":"4","author":"Luthra","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2021.11.002_bb0020","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gutjnl-2016-311835","article-title":"Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis","volume":"66","author":"Nelson","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.tips.2021.11.002_bb0025","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1053\/j.gastro.2018.08.021","article-title":"Efficacy of secretagogues in patients with irritable bowel syndrome with constipation: systematic review and network meta-analysis","volume":"155","author":"Black","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2021.11.002_bb0030","doi-asserted-by":"crossref","first-page":"G637","DOI":"10.1152\/ajpgi.00013.2018","article-title":"Toward an effective peripheral visceral analgesic: responding to the national opioid crisis","volume":"314","author":"Camilleri","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tips.2021.11.002_bb0035","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.lfs.2010.03.015","article-title":"Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract","volume":"86","author":"Bryant","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.tips.2021.11.002_bb0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejphar.2010.09.019","article-title":"Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit","volume":"649","author":"Busby","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2021.11.002_bb0045","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1152\/physrev.00022.2015","article-title":"Molecular physiology of membrane guanylyl cyclase receptors","volume":"96","author":"Kuhn","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tips.2021.11.002_bb0050","doi-asserted-by":"crossref","DOI":"10.5402\/2013\/813648","article-title":"Current understanding of guanylin peptides actions","volume":"2013","author":"Sindic","year":"2013","journal-title":"ISRN Nephrol."},{"key":"10.1016\/j.tips.2021.11.002_bb0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.112.199430","article-title":"Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation","volume":"344","author":"Busby","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2021.11.002_bb0060","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13299","article-title":"Linaclotide activates guanylate cyclase-C\/cGMP\/protein kinase-II-dependent trafficking of CFTR in the intestine","volume":"5","author":"Ahsan","year":"2017","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.tips.2021.11.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93686","article-title":"Guanylate cyclase 2C agonism corrects CFTR mutants","volume":"2","author":"Arora","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.tips.2021.11.002_bb0070","doi-asserted-by":"crossref","first-page":"G868","DOI":"10.1152\/ajpgi.00261.2017","article-title":"Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium\/hydrogen exchanger 3","volume":"315","author":"McHugh","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tips.2021.11.002_bb0075","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coph.2012.10.005","article-title":"Guanylate cyclase-C receptor activation: unexpected biology","volume":"12","author":"Brierley","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tips.2021.11.002_bb0080","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1523\/JNEUROSCI.5114-12.2013","article-title":"Activation of guanylate cyclase-C attenuates stretch responses and sensitization of mouse colorectal afferents","volume":"33","author":"Feng","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.11.002_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnmol.2014.00031","article-title":"Guanylate cyclase-C\/cGMP: an emerging pathway in the regulation of visceral pain","volume":"7","author":"Hannig","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tips.2021.11.002_bb0090","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.pain.2013.05.044","article-title":"Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin\/guanylate cyclase-C\/cGMP activation","volume":"154","author":"Silos-Santiago","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.tips.2021.11.002_bb0095","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2013.08.017","article-title":"Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate","volume":"145","author":"Castro","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2021.11.002_bb0100","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2982.2009.01385.x","article-title":"Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain","volume":"22","author":"Eutamene","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.tips.2021.11.002_bb0105","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1097\/j.pain.0000000000001657","article-title":"Linaclotide treatment reduces endometriosis-associated vaginal hyperalgesia and mechanical allodynia through viscerovisceral cross-talk","volume":"160","author":"Ge","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.tips.2021.11.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121841","article-title":"Chronic linaclotide treatment reduces colitis-induced neuroplasticity and reverses persistent bladder dysfunction","volume":"3","author":"Grundy","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.tips.2021.11.002_bb0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.118.248567","article-title":"Linaclotide attenuates visceral organ crosstalk: role of guanylate cyclase-C activation in reversing bladder-colon cross-sensitization","volume":"366","author":"Mohammadi","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2021.11.002_bb0120","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/ajg.2012.254","article-title":"Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety","volume":"107","author":"Chey","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2021.11.002_bb0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJMoa1010863","article-title":"Two randomized trials of linaclotide for chronic constipation","volume":"365","author":"Lembo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2021.11.002_bb0130","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/ajg.2012.255","article-title":"A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation","volume":"107","author":"Rao","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2021.11.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134349","article-title":"Linaclotide in chronic idiopathic constipation patients with moderate to severe abdominal bloating: a randomized, controlled trial","volume":"10","author":"Lacy","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2021.11.002_bb0140","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3748\/wjg.v24.i17.1888","article-title":"Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models","volume":"24","author":"Boulete","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tips.2021.11.002_bb0145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41395-018-0026-7","article-title":"Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials","volume":"113","author":"Brenner","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2021.11.002_bb0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrgastro.2014.103","article-title":"Neuroplasticity and dysfunction after gastrointestinal inflammation","volume":"11","author":"Brierley","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2021.11.002_bb0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-physiol-020518-114525","article-title":"Visceral pain","volume":"81","author":"Grundy","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.tips.2021.11.002_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13776","article-title":"Critical evaluation of animal models of visceral pain for therapeutics development: a focus on irritable bowel syndrome","volume":"32","author":"Johnson","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.tips.2021.11.002_bb0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1535370219891690","article-title":"The microbiota-gut-brain axis: an emerging role for the epigenome","volume":"245","author":"Louwies","year":"2020","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tips.2021.11.002_bb0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/164_2016_102","article-title":"Irritable bowel syndrome: pathophysiology and current therapeutic approaches","volume":"239","author":"Camilleri","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.tips.2021.11.002_bb0175","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: a clinical review","volume":"313","author":"Chey","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.tips.2021.11.002_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13375","article-title":"Linaclotide inhibits colonic and urinary bladder hypersensitivity in adult female rats following unpredictable neonatal stress","volume":"30","author":"Ligon","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.tips.2021.11.002_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14076","article-title":"Peripheral guanylate cyclase-C modulation of corticolimbic activation and corticotropin-releasing factor signaling in a rat model of stress-induced colonic hypersensitivity","volume":"33","author":"Ligon","year":"2021","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.tips.2021.11.002_bb0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4292\/wjgpt.v6.i4.213","article-title":"Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis","volume":"6","author":"Shailubhai","year":"2015","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2021.11.002_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4292\/wjgpt.v8.i1.47","article-title":"Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc(+\/Min-FCCC) mice","volume":"8","author":"Chang","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2021.11.002_bb0200","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131712","article-title":"Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity","volume":"4","author":"Castro","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.tips.2021.11.002_bb0205","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.14309\/00000434-201710001-00445","article-title":"Effect of linaclotide DR1, a delayed-release formulation of linaclotide, in IBS-C patients: analysis of symptom improvement using responder radar plots","volume":"112","author":"Chey","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2021.11.002_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(19)38317-9","article-title":"Su1578 \u2013 chronic intracolonic administration of linaclotide inhibits nociceptive signaling in a mouse model of chronic visceral hypersensitivity","volume":"156","author":"Castro","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2021.11.002_bb0215","doi-asserted-by":"crossref","first-page":"S-803","DOI":"10.1016\/S0016-5085(20)32687-1","article-title":"Chronic intra-colonic linaclotide administration alters glial activation in a mouse model of chronic visceral hypersensitivity","volume":"158","author":"Harrington","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2021.11.002_bb0220","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/MPG.0000000000003296","article-title":"Intestinal guanylate cyclase-C mRNA expression in duodenum and colon of children","volume":"73","author":"Cohen","year":"2021","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.tips.2021.11.002_bb0225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/jpet.115.224329","article-title":"MRP4 modulation of the guanylate cyclase-C\/cGMP pathway: effects on linaclotide-induced electrolyte secretion and cGMP efflux","volume":"355","author":"Tchernychev","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2021.11.002_bb0230","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.cell.2007.09.037","article-title":"Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia","volume":"131","author":"Li","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.11.002_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(19)37744-3","article-title":"Sa1677 \u2013 chronic colonic administration of the guanylate cyclase-C agonist linaclotide attenuates colitis induced bladder afferent hyperactivity","volume":"156","author":"Grundy","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2021.11.002_bb0240","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2009.12.050","article-title":"Efficacy of linaclotide for patients with chronic constipation","volume":"138","author":"Lembo","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2021.11.002_bb0245","article-title":"Dose-finding study of linaclotide in Japanese patients with chronic constipation: a phase II randomized, double-blind, and placebo-controlled study","volume":"30","author":"Fukudo","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.tips.2021.11.002_bb0250","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/j.gastro.2010.08.041","article-title":"Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation","volume":"139","author":"Johnston","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2021.11.002_bb0255","article-title":"Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: a phase II randomized, double-blind, placebo-controlled study","volume":"30","author":"Fukudo","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.tips.2021.11.002_bb0260","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/jgh.14086","article-title":"Linaclotide in irritable bowel syndrome with constipation: a phase 3 randomized trial in China and other regions","volume":"33","author":"Yang","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2021.11.002_bb0265","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.14309\/ajg.0000000000001334","article-title":"Efficacy of linaclotide in reducing abdominal symptoms of bloating, discomfort, and pain: a phase 3B trial using a novel abdominal scoring system","volume":"116","author":"Chang","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2021.11.002_bb0270","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/apt.15772","article-title":"Randomised clinical trial: linaclotide vs placebo-a study of bi-directional gut and brain axis","volume":"51","author":"Rao","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2021.11.002_bb0275","doi-asserted-by":"crossref","first-page":"354","DOI":"10.14309\/ajg.0000000000000967","article-title":"Randomized trial of 2 delayed-release formulations of linaclotide in patients with irritable bowel syndrome with constipation","volume":"116","author":"Chey","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2021.11.002_bb0280","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/cne.25070","article-title":"Morphological identification of thoracolumbar spinal afferent nerve endings in mouse uterus","volume":"529","author":"Dodds","year":"2021","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tips.2021.11.002_bb0285","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fnins.2018.00931","article-title":"Mechanisms underlying overactive bladder and interstitial cystitis\/painful bladder syndrome","volume":"12","author":"Grundy","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tips.2021.11.002_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.590823","article-title":"Pain in endometriosis","volume":"14","author":"Maddern","year":"2020","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.tips.2021.11.002_bb0295","doi-asserted-by":"crossref","first-page":"G301","DOI":"10.1152\/ajpgi.00272.2017","article-title":"Cross-organ sensitization between the colon and bladder: to pee or not to pee?","volume":"314","author":"Grundy","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tips.2021.11.002_bb0300","doi-asserted-by":"crossref","first-page":"G285","DOI":"10.1152\/ajpgi.00013.2019","article-title":"Colonic afferent input and dorsal horn neuron activation differs between the thoracolumbar and lumbosacral spinal cord","volume":"317","author":"Harrington","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tips.2021.11.002_bb0305","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00441-016-2393-y","article-title":"Cellular localization of guanylin and uroguanylin mRNAs in human and rat duodenal and colonic mucosa","volume":"365","author":"Brenna","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.tips.2021.11.002_bb0310","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.gastro.2015.11.047","article-title":"Human enteroids as a model of upper small intestinal ion transport physiology and pathophysiology","volume":"150","author":"Foulke-Abel","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2021.11.002_bb0315","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2015-309441","article-title":"Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C","volume":"65","author":"Muller","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.tips.2021.11.002_bb0320","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/ejhg.2014.236","article-title":"Meconium ileus in a Lebanese family secondary to mutations in the GUCY2C gene","volume":"23","author":"Smith","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.tips.2021.11.002_bb0325","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/gutjnl-2018-316029","article-title":"Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders","volume":"67","author":"Waldman","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.tips.2021.11.002_bb0330","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2021.11.002_bb0335","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1007\/s10620-013-2684-z","article-title":"Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses","volume":"58","author":"Shailubhai","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tips.2021.11.002_bb0340","series-title":"Physiology of the Gastrointestinal Tract","first-page":"387","article-title":"Extrinsic sensory afferent nerves innervating the gastrointestinal tract in health and disease","author":"Harrington","year":"2018"},{"key":"10.1016\/j.tips.2021.11.002_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112466","article-title":"Identification of different types of spinal afferent nerve endings that encode noxious and innocuous stimuli in the large intestine using a novel anterograde tracing technique","volume":"9","author":"Spencer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2021.11.002_bb0350","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-3-319-27592-5_7","article-title":"Extrinsic sensory innervation of the gut: structure and function","volume":"891","author":"Brookes","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tips.2021.11.002_bb0355","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fncel.2018.00467","article-title":"Spinal afferent innervation of the colon and rectum","volume":"12","author":"Brierley","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tips.2021.11.002_bb0360","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1523\/JNEUROSCI.3369-15.2016","article-title":"P2Y receptors sensitize mouse and human colonic nociceptors","volume":"36","author":"Hockley","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.11.002_bb0365","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/gutjnl-2016-311629","article-title":"Ex vivo study of human visceral nociceptors","volume":"67","author":"McGuire","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.tips.2021.11.002_bb0370","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/gutjnl-2017-315631","article-title":"Single-cell RNAseq reveals seven classes of colonic sensory neuron","volume":"68","author":"Hockley","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.tips.2021.11.002_bb0375","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1523\/JNEUROSCI.0837-18.2018","article-title":"Optogenetic activation of colon epithelium of the mouse produces high-frequency bursting in extrinsic colon afferents and engages visceromotor responses","volume":"38","author":"Makadia","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.11.002_bb0380","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.tins.2019.12.007","article-title":"Epithelial-neuronal communication in the colon: implications for visceral pain","volume":"43","author":"Najjar","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2021.11.002_bb0385","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/j.pain.0000000000002110","article-title":"Optogenetic inhibition of the colon epithelium reduces hypersensitivity in a mouse model of inflammatory bowel disease","volume":"162","author":"Najjar","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.tips.2021.11.002_bb0390","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/j.gastro.2020.09.030","article-title":"Sympathetic input to multiple cell types in mouse and human colon produces region-specific responses","volume":"160","author":"Smith-Edwards","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2021.11.002_bb0395","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/j.gastro.2019.04.034","article-title":"Extrinsic primary afferent neurons link visceral pain to colon motility through a spinal reflex in mice","volume":"157","author":"Smith-Edwards","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721002170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721002170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:18:23Z","timestamp":1778721503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614721002170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0165614721002170"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2021.11.002","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2021.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}